These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9121817)

  • 1. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine.
    Calcutt NA; Jorge MC; Yaksh TL; Chaplan SR
    Pain; 1996 Dec; 68(2-3):293-9. PubMed ID: 9121817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor.
    Calcutt NA; Freshwater JD; Mizisin AP
    Diabetologia; 2004 Apr; 47(4):718-24. PubMed ID: 15298349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B vitamins alleviate indices of neuropathic pain in diabetic rats.
    Jolivalt CG; Mizisin LM; Nelson A; Cunha JM; Ramos KM; Bonke D; Calcutt NA
    Eur J Pharmacol; 2009 Jun; 612(1-3):41-7. PubMed ID: 19393643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
    Yadav SK; Nagori BP; Desai PK
    J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of sensory function and antihyperalgesic properties of a prosaposin-derived peptide in diabetic rats.
    Calcutt NA; Freshwater JD; O'Brien JS
    Anesthesiology; 2000 Nov; 93(5):1271-8. PubMed ID: 11046216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve injury-induced tactile allodynia is mediated via ascending spinal dorsal column projections.
    Sun H; Ren K; Zhong CM; Ossipov MH; Malan TP; Lai J; Porreca F
    Pain; 2001 Feb; 90(1-2):105-11. PubMed ID: 11166976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors.
    Cunha JM; Jolivalt CG; Ramos KM; Gregory JA; Calcutt NA; Mizisin AP
    Metabolism; 2008 Jul; 57(7):873-81. PubMed ID: 18555826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fosinopril Prevents the Development of Tactile Allodynia in a Streptozotocin-Induced Diabetic Rat Model.
    Araiza-Saldaña CI; Pedraza-Priego EF; Torres-López JE; Rocha-González HI; Castañeda-Corral G; Hong-Chong E; Granados-Soto V
    Drug Dev Res; 2015 Dec; 76(8):442-9. PubMed ID: 26349482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine attenuates the development of diabetic-induced tactile allodynia by inhibiting microglial activation.
    Suzuki N; Hasegawa-Moriyama M; Takahashi Y; Kamikubo Y; Sakurai T; Inada E
    Anesth Analg; 2011 Oct; 113(4):941-6. PubMed ID: 21788310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac sympathetic neuropathy and effects of aldose reductase inhibitor in streptozotocin-induced diabetic rats.
    Kurata C; Okayama K; Wakabayashi Y; Shouda S; Mikami T; Tawarahara K; Sugiyama T
    J Nucl Med; 1997 Nov; 38(11):1677-80. PubMed ID: 9374332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of naringenin in protection against diabetic hyperalgesia and tactile allodynia in male Wistar rats.
    Hasanein P; Fazeli F
    J Physiol Biochem; 2014 Dec; 70(4):997-1006. PubMed ID: 25407136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat-another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats.
    Prnova MS; Kovacikova L; Svik K; Bezek S; Elmazoğlu Z; Karasu C; Stefek M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):651-661. PubMed ID: 31802170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acute versus continuous glycemic control on duration of local anesthetic sciatic nerve block in diabetic rats.
    Kroin JS; Buvanendran A; Tuman KJ; Kerns JM
    Reg Anesth Pain Med; 2012; 37(6):595-600. PubMed ID: 22996200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain.
    Lynch JJ; Jarvis MF; Kowaluk EA
    Eur J Pharmacol; 1999 Jan; 364(2-3):141-6. PubMed ID: 9932716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil and glyceryl trinitrate reduce tactile allodynia in streptozotocin-injected rats.
    Araiza-Saldaña CI; Rocha-González HI; Ambriz-Tututi M; Castañeda-Corral G; Caram-Salas NL; Hong E; Granados-Soto V
    Eur J Pharmacol; 2010 Apr; 631(1-3):17-23. PubMed ID: 20079349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hydrogen sulfide in the pain processing of non-diabetic and diabetic rats.
    Velasco-Xolalpa ME; Barragán-Iglesias P; Roa-Coria JE; Godínez-Chaparro B; Flores-Murrieta FJ; Torres-López JE; Araiza-Saldaña CI; Navarrete A; Rocha-González HI
    Neuroscience; 2013 Oct; 250():786-97. PubMed ID: 23830907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling diabetic sensory neuropathy in rats.
    Calcutt NA
    Methods Mol Med; 2004; 99():55-65. PubMed ID: 15131329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.
    Ashizawa N; Yoshida M; Sugiyama Y; Akaike N; Ohbayashi S; Aotsuka T; Abe N; Fukushima K; Matsuura A
    Jpn J Pharmacol; 1997 Feb; 73(2):133-44. PubMed ID: 9074947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes].
    Kuchmerovskaia TM; Donchenko GV; Klimenko AP; Chichkovskaia GV; Pakirbaeva LV; Kozitskiĭ ZIa; Efimov AS
    Ukr Biokhim Zh (1978); 1997; 69(3):77-82. PubMed ID: 9505366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive action of a p38alpha MAPK inhibitor, SD-282, in a diabetic neuropathy model.
    Sweitzer SM; Medicherla S; Almirez R; Dugar S; Chakravarty S; Shumilla JA; Yeomans DC; Protter AA
    Pain; 2004 Jun; 109(3):409-419. PubMed ID: 15157702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.